118 related articles for article (PubMed ID: 35591805)
1. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States.
Kahla JA; Siegel DA; Dai S; Lupo PJ; Foster JH; Scheurer ME; Heczey AA
Pediatr Blood Cancer; 2022 Oct; 69(10):e29763. PubMed ID: 35591805
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study.
Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS
J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762
[TBL] [Abstract][Full Text] [Related]
3. Predictors of survival and incidence of hepatoblastoma in the paediatric population.
Allan BJ; Parikh PP; Diaz S; Perez EA; Neville HL; Sola JE
HPB (Oxford); 2013 Oct; 15(10):741-6. PubMed ID: 23600968
[TBL] [Abstract][Full Text] [Related]
4. Incidence and trends of hepatic cancer among children and adolescents in the United States from 2000 to 2017: Evidence from the Surveillance, Epidemiology, and End Results registry data.
Li P; Kong Y; Guo J; Ji X; Han X; Zhang B
Cancer Causes Control; 2023 Jan; 34(1):69-79. PubMed ID: 36244051
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019.
Campbell K; Siegel DA; Umaretiya PJ; Dai S; Heczey A; Lupo PJ; Schraw JM; Thompson TD; Scheurer ME; Foster JH
Pediatr Blood Cancer; 2024 Jan; 71(1):e30732. PubMed ID: 37867409
[TBL] [Abstract][Full Text] [Related]
6. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study.
Feng J; Polychronidis G; Heger U; Frongia G; Mehrabi A; Hoffmann K
Cancer Commun (Lond); 2019 Oct; 39(1):62. PubMed ID: 31651371
[TBL] [Abstract][Full Text] [Related]
7. Surgical Therapy for Pediatric Hepatoblastoma in the USA over the Last Decade: Analysis of the National Cancer Database.
Kulkarni S; Brauer DG; Turmelle Y; Stoll J; Nadler M; Chapman WC; Doyle MB; Khan AS
J Gastrointest Cancer; 2021 Jun; 52(2):547-556. PubMed ID: 32458263
[TBL] [Abstract][Full Text] [Related]
8. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001-2017.
McEvoy MT; Siegel DA; Dai S; Okcu MF; Zobeck M; Venkatramani R; Lupo PJ
Cancer Med; 2023 Feb; 12(3):3644-3656. PubMed ID: 36069287
[TBL] [Abstract][Full Text] [Related]
9. A population-based assessment of metastatic hepatoblastoma in Texas reveals ethnic disparities.
Espinoza AF; Scheurer ME; Chambers TM; Vasudevan SA; Lupo PJ
Front Public Health; 2023; 11():1049727. PubMed ID: 36895691
[TBL] [Abstract][Full Text] [Related]
10. Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020.
Arnett A; Siegel DA; Dai S; Thompson TD; Foster J; di Pierro EJ; Momin B; Lupo PJ; Heczey A
medRxiv; 2024 Apr; ():. PubMed ID: 38633779
[TBL] [Abstract][Full Text] [Related]
11. Survival trends in children with hepatoblastoma.
Horton JD; Lee S; Brown SR; Bader J; Meier DE
Pediatr Surg Int; 2009 May; 25(5):407-12. PubMed ID: 19308432
[TBL] [Abstract][Full Text] [Related]
12. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.
Jemal A; Ward EM; Johnson CJ; Cronin KA; Ma J; Ryerson B; Mariotto A; Lake AJ; Wilson R; Sherman RL; Anderson RN; Henley SJ; Kohler BA; Penberthy L; Feuer EJ; Weir HK
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376154
[TBL] [Abstract][Full Text] [Related]
13. A review of 218 pediatric cases of hepatocellular carcinoma.
Allan BJ; Wang B; Davis JS; Parikh PP; Perez EA; Neville HL; Sola JE
J Pediatr Surg; 2014 Jan; 49(1):166-71; discussion 171. PubMed ID: 24439603
[TBL] [Abstract][Full Text] [Related]
14. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability.
Delavar A; Barnes JM; Wang X; Johnson KJ
JAMA Pediatr; 2020 May; 174(5):428-436. PubMed ID: 32091555
[TBL] [Abstract][Full Text] [Related]
16. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities.
Cruz RJ; Ranganathan S; Mazariegos G; Soltys K; Nayyar N; Sun Q; Bond G; Shaw PH; Haberman K; Krishnamurti L; Marsh JW; Humar A; Sindhi R
Surgery; 2013 Feb; 153(2):150-9. PubMed ID: 23331862
[TBL] [Abstract][Full Text] [Related]
17. Racial/ethnic and socioeconomic survival disparities for children and adolescents with central nervous system tumours in the United States, 2000-2015.
Mitchell HK; Morris M; Ellis L; Abrahão R; Bonaventure A
Cancer Epidemiol; 2020 Feb; 64():101644. PubMed ID: 31783249
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of primary hepatic malignancies in U.S. children.
Darbari A; Sabin KM; Shapiro CN; Schwarz KB
Hepatology; 2003 Sep; 38(3):560-6. PubMed ID: 12939582
[TBL] [Abstract][Full Text] [Related]
19. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Ness KK; Bhatia S; Gurney JG
JAMA; 2003 Oct; 290(15):2008-14. PubMed ID: 14559954
[TBL] [Abstract][Full Text] [Related]
20. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
